PMID- 16924692 OWN - NLM STAT- MEDLINE DCOM- 20070220 LR - 20191210 IS - 0315-162X (Print) IS - 0315-162X (Linking) VI - 33 IP - 10 DP - 2006 Oct TI - Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis. PG - 1936-41 AB - OBJECTIVE: To evaluate and determine prognostic factors of 5-year quality of life in patients with early rheumatoid arthritis (RA). METHODS: A cohort of 191 patients with RA and disease duration < 1 year was prospectively followed over 5 years. The outcome measure was quality of life as assessed by the Arthritis Impact Measurement Scales 2 (AIMS2). Univariate analysis, then stepwise multiple logistic regression, was used to find independent baseline prognostic variables. RESULTS: After accounting for death, loss of followup, and missing data, 158 patients (82.72%) were included in the analysis. The mean AIMS2 physical, symptom, psychological, social interaction, and work scores after 5 years were 1.6 (range 0-6.88), 4.0 (0-10), 3.48 (0-9.22), 4.06 (0-8.69), and 1.87 (0-8.13), respectively. The AIMS2 physical component was significantly correlated with Health Assessment Questionnaire (HAQ) score at 5 years. Logistic regression analysis revealed that the baseline values able to predict the 5-year physical, psychological, symptom, social interaction, and work status were, respectively: HAQ score and erythrocyte sedimentation rate (ESR), body mass index (BMI), HAQ; erosion score and sex, HAQ; ESR and anti-perinuclear antibody; matrix metalloproteinase-3 (MMP3) level, joint space narrowing, and tender joint scores; HAQ score and age. CONCLUSION: The multidimensional structure of the AIMS2 allowed us to assess the 5-year health-related quality of life in early RA. Using this instrument as an outcome variable, prognostic factors were selected and varied widely depending on the evaluated domain. The baseline HAQ score was the best predictive factor of 4 of the 5 domains of the AIMS2. FAU - Cohen, Jean-David AU - Cohen JD AD - Department of Immuno-Rhumatologie, CHU Montpellier, Montpellier I University and INSERM U454, Montpellier, France. FAU - Dougados, Maxime AU - Dougados M FAU - Goupille, Philippe AU - Goupille P FAU - Cantagrel, Alain AU - Cantagrel A FAU - Meyer, Olivier AU - Meyer O FAU - Sibilia, Jean AU - Sibilia J FAU - Daures, Jean-Pierre AU - Daures JP FAU - Combe, Bernard AU - Combe B LA - eng PT - Evaluation Study PT - Journal Article DEP - 20060815 PL - Canada TA - J Rheumatol JT - The Journal of rheumatology JID - 7501984 RN - 0 (Antirheumatic Agents) SB - IM CIN - Nat Clin Pract Rheumatol. 2007 Jul;3(7):380-1. PMID: 17549087 MH - Adult MH - Antirheumatic Agents/therapeutic use MH - Arthritis, Rheumatoid/*complications/diagnostic imaging/drug therapy/*psychology MH - Female MH - Humans MH - Logistic Models MH - Longitudinal Studies MH - Male MH - Middle Aged MH - *Outcome Assessment, Health Care MH - Predictive Value of Tests MH - Prognosis MH - Prospective Studies MH - *Quality of Life MH - Radiography MH - Severity of Illness Index MH - *Surveys and Questionnaires MH - Treatment Outcome EDAT- 2006/08/23 09:00 MHDA- 2007/02/21 09:00 CRDT- 2006/08/23 09:00 PHST- 2006/08/23 09:00 [pubmed] PHST- 2007/02/21 09:00 [medline] PHST- 2006/08/23 09:00 [entrez] AID - 06/13/0813 [pii] PST - ppublish SO - J Rheumatol. 2006 Oct;33(10):1936-41. Epub 2006 Aug 15.